These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 988451)

  • 1. [Levels of selenium in urine after treatment of pityriasis versicolor with a 1.0% selenium sulfide].
    Costa Martins JE; Macedo De Souza E; Salebian A; Sampaio SA
    Med Cutan Ibero Lat Am; 1976; 4(2):137-41. PubMed ID: 988451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Itraconazole in the treatment of pityriasis versicolor: comparison between 5 and 7 days of treatment].
    Cucé LC; Belda Júnior W; Ribeiro EB
    Rev Inst Med Trop Sao Paulo; 1990; 32(3):181-4. PubMed ID: 1966916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy and safety of the new antimycotic sertaconazole in the treatment of Pityriasis versicolor.
    Nasarre J; Umbert P; Herrero E; Roset P; Márquez M; Torres J; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):764-7. PubMed ID: 1627203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized comparative clinical trial of itraconazole and selenium sulfide shampoo for the treatment of pityriasis versicolor.
    del Palacio Hernanz A; Delgado Vicente S; Menéndez Ramos F; Rodríguez-Noriega Belaustegui A
    Rev Infect Dis; 1987; 9 Suppl 1():S121-7. PubMed ID: 3027836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selenium sulfide in tinea versicolor: blood and urine levels.
    Sánchez JL; Torres VM
    J Am Acad Dermatol; 1984 Aug; 11(2 Pt 1):238-41. PubMed ID: 6480923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pityriasis versicolor in Greece and its predisposition factors].
    Parisis N; Stratigos J; Marcelou-Kinti U; Capetanakis J
    Hautarzt; 1977 Nov; 28(11):589-92. PubMed ID: 23362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and tolerability of Ketomousse (ketoconazole foam 1%) and ketoconazole cream 2% in the treatment of pityriasis versicolor: results of a prospective, multicentre, randomised study.
    Di Fonzo EM; Martini P; Mazzatenta C; Lotti L; Alvino S
    Mycoses; 2008 Nov; 51(6):532-5. PubMed ID: 18422916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid response of transient acantholytic dermatosis to selenium sulfide treatment for pityriasis versicolor.
    Segal R; Alteras I; Sandbank M
    Dermatologica; 1987; 175(4):205-7. PubMed ID: 3653468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a single 400 mg dose versus a 7-day 200 mg daily dose of itraconazole in the treatment of tinea versicolor.
    Köse O; Bülent Taştan H; Riza Gür A; Kurumlu Z
    J Dermatolog Treat; 2002 Jun; 13(2):77-9. PubMed ID: 12060506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience with fenticonazole 2% formulation in the treatment of dermatomycoses and pityriasis versicolor.
    Aste N; Pau M; Zucca M; Biggio P
    Int J Clin Pharmacol Res; 1987; 7(6):503-6. PubMed ID: 3440641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of ketoconazole versus selenium sulphide shampoo in pityriasis versicolor.
    Aggarwal K; Jain VK; Sangwan S
    Indian J Dermatol Venereol Leprol; 2003; 69(2):86-7. PubMed ID: 17642841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A double-blind placebo-controlled study of a 2 percent foaming lotion of ketoconazole in a single application in the treatment of pityriasis versicolor].
    Rekacewicz I; Guillaume JC; Benkhraba F; Archimbaud A; Baspeyras M; Boitier F; Bussière M; Coin A; Di Crezenzo MC; Duval J
    Ann Dermatol Venereol; 1990; 117(10):709-11. PubMed ID: 2073061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pityriasis versicolor: a systematic review of interventions.
    Hu SW; Bigby M
    Arch Dermatol; 2010 Oct; 146(10):1132-40. PubMed ID: 20956647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current treatment of cutaneous Pityrosporum and Candida-infections.
    Faergemann J
    Acta Derm Venereol Suppl (Stockh); 1986; 121():109-16. PubMed ID: 3459338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of oral and topical ketoconazole therapy in pityriasis versicolor.
    Nagpal VB; Jain VK; Aggarwal K
    Indian J Dermatol Venereol Leprol; 2003; 69(4):287-8. PubMed ID: 17642914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Croconazole: a new broad spectrum agent in the treatment of fungal skin infections.
    Meinicke K; Michel G
    Int J Clin Pharmacol Res; 1994; 14(4):139-48. PubMed ID: 7607787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mycological efficacy and safety of selenium sulfide 1.8% versus ketoconazole 2% shampoo in pityriasis versicolor: A double-blind randomized controlled trial.
    Lusiana ; Surachmiati L; Saldi SRF; Lusianingtyas T; Bramono K
    Germs; 2022 Dec; 12(4):452-460. PubMed ID: 38021181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pityriasis versicolor.
    Faergemann J
    Semin Dermatol; 1993 Dec; 12(4):276-9. PubMed ID: 8312142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Local therapy of pityriasis versicolor with 3 imidazole derivatives--results of a therapeutic study. Studies of the rate of recurrence].
    Senff H; Bothe C; Riemann U; Reinel D
    Z Hautkr; 1988 Dec; 63(12):1005-8. PubMed ID: 3218286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.